Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.

Last updated on 4-11-2022 by Géraldine Daneau

Public Access


Peer reviewed scientific article



Article written during project(s) : 


BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in people with cystic fibrosis (pwCF) can lead to severe outcomes. METHODS: In this observational study, the European Cystic Fibrosis Society Patient Registry collected data on pwCF and SARS-CoV-2 infection to estimate incidence, describe clinical presentation and investigate factors associated with severe outcomes using multivariable analysis. RESULTS: Up to December 31, 2020, 26 countries reported information on 828 pwCF and SARS-CoV-2 infection. Incidence was 17.2 per 1000 pwCF (95% CI: 16.0-18.4). M…

Associated health topics:

QR code

QR code for this page URL